SmPC | Summary of Product Characteristics

Summary of Product Characteristics

The Summary of Product Characteristics (SmPC) is a regulatory document providing detailed information on a medicine: indications, dosage, contraindications, adverse effects, and precautions. Intended for healthcare professionals, it is the official reference for compliant and safe use.

SmPCs are validated during MA and regularly updated.

The SmPC (Summary of Product Characteristics) is the authoritative, regulatory document that describes how a medicinal product should be used in clinical practice.

Approved by regulatory authorities as part of the marketing authorisation, the SmPC provides essential information for healthcare professionals on the product’s indications, dosing, contraindications, pharmacology, safety profile, and handling requirements.

The SmPC serves as the legal basis for the safe and effective use of medicines in the EU and forms the foundation for patient-facing documents such as the Package Leaflet.

The SmPC ensures that healthcare professionals have access to accurate, consistent, and up-to-date information about a medicinal product.

Its objectives are to:

• Provide clear instructions on posology, administration, and therapeutic indications
• Describe known risks, contraindications, and precautions
• Summarise pharmacological data supporting the product’s benefit–risk profile
• Guide prescribers, pharmacists, and other professionals in making informed decisions
• Establish the reference standard for promotional and educational material

The content of the SmPC is legally binding and must reflect the current scientific knowledge and post-authorisation data.

The SmPC follows a harmonised format defined in EU legislation and guidance. The main sections include:

1. Name, Composition, and Pharmaceutical Form

Identifies the medicinal product, active substances, excipients of known effect, and dosage form.

2. Clinical Information

Covers the key clinical aspects of use, including:

• Therapeutic indications
• Posology and method of administration
• Contraindications
• Special warnings and precautions
• Interaction with other medicinal products
• Use in pregnancy and lactation
• Effects on ability to drive or operate machinery
• Undesirable effects
• Overdose management

3. Pharmacological Properties

Describes:

• Pharmacodynamic properties
• Pharmacokinetic characteristics
• Preclinical safety data

4. Pharmaceutical Particulars

Includes:

• Shelf life and storage conditions
• Incompatibilities
• Container and packaging description
• Instructions for handling and disposal

5. Administrative Information

Lists marketing authorisation details, MAH contact information, and revision dates.

The SmPC is a central document in the EU regulatory framework:

• It is approved by regulatory authorities and must be kept current.
• It informs pharmacovigilance activities, risk-management measures, and labelling updates.
• It is referenced by healthcare professionals for prescribing, dispensing, and counselling.
• It underpins the creation of the PL (Package Leaflet) and labelling texts.